Michael Stubblefield, Avantor CEO
September 7, 2021 10:46 AM EDTUpdated 11:19 AM
Manufacturing

Dou­bling down on need for mR­NA vac­cines and mAbs, Avan­tor puts near­ly $3B in pumps and tub­ing com­pa­ny

Josh Sullivan

Ac­qui­si­tion-hap­py man­u­fac­tur­er Avan­tor has po­si­tioned it­self at the front of the bat­tle against Covid-19, and Tues­day it made an­oth­er move to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

WuXi com­pa­nies may sell units im­pact­ed by Biose­cure — re­port

Sanofi sells rare dis­ease drug En­jay­mo to Recor­dati for $825M up­front

Biotech's third quar­ter was rel­a­tive­ly bright — with a few caveats

Ex­clu­sive: Af­ter dis­cov­er­ing an­tibi­otics with AI, a 31-year-old first-time CEO rais­es $17M to fight ag­ing

EMA re­views hair loss prod­ucts fol­low­ing con­cerns about sui­ci­dal thoughts

sponsored

3 Tiers for AAV Po­ten­cy As­say De­vel­op­ment Suc­cess

A service from the Financial Times